Arnicolide C Suppresses Tumor Progression by Targeting 14-3-3θ in Breast Cancer.

Authors:
Liu Z; Lyu X; Chen J; Zhang B; Xie S and 6 more

Journal:
Pharmaceuticals (Basel)

Publication Year: 2024

DOI:
10.3390/ph17020224

PMCID:
PMC10892132

PMID:
38399439

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pharmaceuticals (Basel)

Abbreviation: Pharmaceuticals (Basel)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
1,2,4-Triazole-Tethered Indolinones as New Cancer-Fighting Small Molecules Targeting VEGFR-2: Synth…
Elsawi AE; Shahin MI; Elbendary HA and 3 more (2024) - Transparency Score: 3/6
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Al Shaer D; Al Musaimi O; Albericio F and 1 more (2024) - Transparency Score: 3/6
Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice.
Zhang C; Su H; Waight E and 4 more (2024) - Transparency Score: 3/6
A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Cr…
Kokoszka A. (2024) - Transparency Score: 3/6
A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular…
Chen LZ; Roos D; Philip E and 4 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare no conflicts of interest."

Evidence found in paper:

"This research project was financially supported by the National Natural Science Foundation of China (No. 82272668), the National Natural Science Foundation of China (No. 82304541), the Natural Science Foundation of Jiangsu Province (No. BK20221036), the Jiangsu Funding Program for Excellent Postdoctoral Talent (No. 1412200065), and the Project Foundation of Taizhou School of Clinical Medicine, Nanjing Medical University (Grant No. TZKY20220205)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025